It was the IPO that wasnt A biotech firm hit the market and traded for six days only to announce Friday that it wasnt issuing shares after all thanks to a key investors failure to follow through on a commitment to buy stock  That meant all the investors who thought they had bought or sold shares in Vascular Biogenics Ltd since it began trading hadnt The
  